作者：
Conrado, D. J. [1]
;
Burton, J. [2]
;
Maciuca, R. [3]
;
Willis, B. [4]
;
Sinha, V. [5]
;
Nicholas, T. [6]
;
Stone, J. [7]
;
Chen, D. [8]
;
Coello, N. [9]
;
Wang, W. [10]
;
Ahamadi, M. [11]
;
Macha, S. [12]
;
Yang, M. [13]
;
Chen, C. [14]
;
Weidemann, J. [15]
;
Bani, M. ;
Boroojerdi, B. ;
Muglia, P. ;
Raybon, J. ;
Gold, M. ;
Gallagher, J. ;
Dexter, D. ;
Hynds, R. ;
Kern, V. D. ;
Stephenson, D. ;
Arneric, S. P. ;
Romero, K.
作者单位：
Abbvie, Chicago, IL USA
[1]
Pfizer, Cambridge, MA USA
[2]
Pfizer, Groton, CT USA
[3]
Lundbeck, Copenhagen, Denmark
[4]
UCB, Brussels, Belgium
[5]
GSK, Brentford, England
[6]
Parkinsons United Kingdom, London, England
[7]
Novartis Pharmaceut, E Hanover, NJ USA
[8]
Crit Path Inst, Cambridge, MA USA
[9]
Biogen, Cambridge, MA USA
[10]
Crit Path Inst, Tucson, AZ USA
[11]
Novartis Pharmaceut, Basel, Switzerland
[12]
Denali, San Francisco, CA USA
[13]
Eli Lilly & Co, Indianapolis, IN 46285 USA
[14]
Merck & Co Inc, N Wales, PA USA
[15]
发布时间
2020-08-12
换一批
